Gene hunt aims to prevent liver damage in MS patients
NCT ID NCT01118130
First seen Jan 21, 2026 · Last updated May 24, 2026 · Updated 10 times
Summary
This study looked at 300 people with multiple sclerosis (MS) to see if certain genes are linked to liver injury caused by beta-interferon, a common MS treatment. Researchers compared patients who had liver damage to those who did not. The goal was to find genetic markers that could help predict and prevent this side effect in the future.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dalhousie MS Research Unit
Halifax, Nova Scotia, Canada
-
Hôpital Notre-Dame MS clinic
Montreal, Quebec, Canada
-
London Health Sciences Centre MS clinic
London, Ontario, Canada
-
MS Clinic UBC Hospital
Vancouver, British Columbia, V6T 2B5, Canada
-
Winnipeg Health Sciences Centre
Winnipeg, Manitoba, Canada
Conditions
Explore the condition pages connected to this study.